Clik here to view.
Invivoscribe任命Loui Madakamutil为首席科学官，领导公司治疗学部门
圣迭戈 (美国商业资讯)–开发恶性血液肿瘤诊断产品和试剂并进行商业化的行业先驱Invivoscribe, Inc.今天宣布，领导团队增聘关键成员来领导其一体化药物开发引擎Invivoscribe Therapeutics, Inc.。 Invivoscribe...
View ArticleClik here to view.
インビボスクライブがLoui Madakamutilを治療薬部門をけん引する最高科学責任者に任命
サンディエゴ （ビジネスワイヤ） — 血液悪性腫瘍向けの診断製品と試薬の開発・商品化を手掛ける業界パイオニアのインビボスクライブは本日、当社の完全統合型の医薬品開発エンジンの指揮を取ってもらうべく、経営陣の重要メンバーを採用したと発表しました。...
View ArticleClik here to view.
BeiGene to Present at the Morgan Stanley 18th Annual Global Healthcare...
CAMBRIDGE, Mass. & BEIJING BeiGene, Ltd. (NASDAQ:BGNE; HKEX:06160), a commercial-stage biotechnology company focused on developing and commercializing innovative medicines worldwide, today...
View ArticleClik here to view.
HiFiBiO Therapeutics Announces a Global Strategic Partnership With ABL Bio...
CAMBRIDGE, Mass. & PARIS & SHANGHAI & HONG KONG HiFiBiO Therapeutics, a clinical-stage multinational biotherapeutics company focused on the development of novel antibodies in...
View ArticleClik here to view.
Daiichi Sankyo Initiates Phase 2 Study of Patritumab Deruxtecan in Patients...
TOKYO & BASKING RIDGE, N.J. & MUNICH Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) announced today that the first patient has been dosed in a phase 2 study evaluating...
View ArticleClik here to view.
Guided Therapeutics Ships LuViva Devices and Disposables for Chinese FDA...
PEACHTREE CORNERS, Ga. Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced that it had shipped four...
View ArticleClik here to view.
EpimAb Biotherapeutics Announces FDA Clearance of its IND Application for...
SHANGHAI EpimAb Biotherapeutics, a clinical stage biotech company specializing in bispecific antibodies, today announced that it has received “STUDY MAY PROCEED” letter from the U.S. Food and Drug...
View ArticleClik here to view.
Forma Therapeutics Appoints Two New Vice Presidents to Lead Key...
WATERTOWN, Mass. Forma Therapeutics Holdings, Inc. (Nasdaq: FMTX), a clinical-stage biopharmaceutical company focused on rare hematologic diseases and cancers, today announced the appointments of...
View ArticleClik here to view.
Takeda Opens New R&D Cell Therapy Manufacturing Facility to Support Expansion...
OSAKA, Japan Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced the expansion of its cell therapy manufacturing capabilities with the opening of a new 24,000...
View ArticleClik here to view.
Exelixis Announces Takeda and Ono Submit Supplemental Application for...
ALAMEDA, Calif. Exelixis, Inc. (NASDAQ: EXEL) today announced that Takeda Pharmaceutical Company Limited (Takeda), its partner responsible for the clinical development and commercialization of...
View ArticleClik here to view.
Prokarium Closes $21M Series B Financing Round and Strengthens Board
LONDON Prokarium, a privately-held biotechnology company developing novel immunotherapies and vaccines based on its engineered microbial platform, today announced the closing of a Series B...
View ArticleClik here to view.
Prokarium Closes $21M Series B Financing Round and Strengthens Board
LONDON Prokarium, a privately-held biotechnology company developing novel immunotherapies and vaccines based on its engineered microbial platform, today announced the closing of a Series B...
View ArticleClik here to view.
Crown Bioscience Increases APAC Capacity with New Facility in Zhongshan, China
SAN DIEGO, Calif. Crown Bioscience, a JSR Life Sciences company, today announces the opening of a new oncology-focused research facility in Zhongshan, China to satisfy increased customer demand....
View ArticleClik here to view.
Crown Bioscience Increases APAC Capacity with New Facility in Zhongshan, China
SAN DIEGO, Calif. Crown Bioscience, a JSR Life Sciences company, today announces the opening of a new oncology-focused research facility in Zhongshan, China to satisfy increased customer demand....
View ArticleClik here to view.
Takeda Expands COVID-19 Vaccine Supply in Japan Through Partnership with...
OSAKA, Japan Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK), announced today that it will import and distribute 50 million doses of Moderna’s COVID-19 vaccine candidate, mRNA-1273,...
View ArticleClik here to view.
武田薬品工業:...
大阪 （ビジネスワイヤ） – 武田薬品工業株式会社（TSE:4502/NYSE:TAK）は、本日、2020年度上期の業績を公表しましたのでお知らせします。 当社代表取締役社長CEOのクリストフ・ウェバーは次のように述べています。...
View ArticleClik here to view.
Takeda FY2020 H1 Results Demonstrate Portfolio Resilience; Confirms Full-Year...
OSAKA, Japan Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced financial results for the first half of fiscal year 2020 (period ended September 30, 2020). TAKEDA...
View ArticleClik here to view.
Sengenics Launches SEROMAX, an At-Home, Antibody Sample Collection Kit That...
SINGAPORE Sengenics, the Functional Proteomics Company, today announced the launch of SEROMAX, a sample collection kit which only requires a pin-prick amount of blood for quantifying antibodies or...
View ArticleClik here to view.
Clik here to view.
DESTINY-Breast05 Head-to-Head Phase 3 Trial of ENHERTU® Versus T-DM1...
TOKYO & MUNICH & BASKING RIDGE, N.J. Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) and AstraZeneca today announced the initiation of DESTINY-Breast05, a global phase 3,...
View Article